SLC7A11 and cancer: Additionally, combining SLC7A11 inhibitors with other therapeutic agents, such as chemotherapy or immunotherapy, could result in synergistic effects, thereby enhancing treatment outcomes for patients with advanced-stage cancers (Hong et al., 2021).